Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: david nordic who wrote (301)	5/12/2010 12:59:41 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 507

The stock is strong today..but moves all over the board with such small volume. Who knows why Barclay would time such a report....IMO the news coming out of ASCO 'should' be all positive. It could have been the news from (MPPP) yesterday....excellent news but time frame to submission put revenue potential out to two years. With the pipeline these guys have......will only take a few to jack the revenue numbers. The only worry is that their former 'neighbor', same building complex was NUVO......so I hope none of NUVO luck rubs off on NKTR. Good luck....now sit back and wait for ASCO--but the abstracts should be available next week...I think!